(Q36490759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Vaccination for treatment and prevention of cancer in animal models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Cornelis J. M. Melief

5

object named as

Cornelis J M Melief

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sjoerd H van der Burg

3

object named as

Sjoerd H van der Burg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Rienk Offringa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Guido Forni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

published in

Advances in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

175-213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730264%20AND%20SRC:MED&resulttype=core&format=json

Genetic immunization against neu/erbB2 transgenic breast cancer

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD4+T Cells Are Able to Promote Tumor Growth through Inhibition of Tumor-Specific CD8+T-Cell Responses in Tumor-Bearing Hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Novel conjugates of epitope fusion peptides with CpG-ODN display enhanced immunogenicity and HIV recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CTLA-4: new insights into its biological function and use in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD4+ Tregs and immune control

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cancer immunoprevention: tracking down persistent tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cancer immunoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTY-Neu transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Strategies for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cancer immunology: cat and mouse games

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Immunobiology of her-2/neu transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Molecular characterization of the T cell repertoire using immunoscope analysis and its possible implementation in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Peptide-induced antiviral protection by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Immunological inhibition of carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Revival of the regulatory T cell: new targets for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

CD4 T cells and their role in antitumor immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990005-4

7 January 2021